242 related articles for article (PubMed ID: 34768595)
1. Clinical Features of LMNA-Related Cardiomyopathy in 18 Patients and Characterization of Two Novel Variants.
Ferradini V; Cosma J; Romeo F; De Masi C; Murdocca M; Spitalieri P; Mannucci S; Parlapiano G; Di Lorenzo F; Martino A; Fedele F; Calò L; Novelli G; Sangiuolo F; Mango R
J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768595
[TBL] [Abstract][Full Text] [Related]
2. Case reports of a c.475G>T, p.E159* lamin A/C mutation with a family history of conduction disorder, dilated cardiomyopathy and sudden cardiac death.
Yokokawa T; Ichimura S; Hijioka N; Kaneshiro T; Yoshihisa A; Kunii H; Nakazato K; Ishida T; Suzuki O; Ohno S; Aiba T; Ohtani H; Takeishi Y
BMC Cardiovasc Disord; 2019 Dec; 19(1):298. PubMed ID: 31847799
[TBL] [Abstract][Full Text] [Related]
3. Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy.
Forleo C; Carmosino M; Resta N; Rampazzo A; Valecce R; Sorrentino S; Iacoviello M; Pisani F; Procino G; Gerbino A; Scardapane A; Simone C; Calore M; Torretta S; Svelto M; Favale S
PLoS One; 2015; 10(4):e0121723. PubMed ID: 25837155
[TBL] [Abstract][Full Text] [Related]
4. Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy.
Perrot A; Hussein S; Ruppert V; Schmidt HH; Wehnert MS; Duong NT; Posch MG; Panek A; Dietz R; Kindermann I; Böhm M; Michalewska-Wludarczyk A; Richter A; Maisch B; Pankuweit S; Ozcelik C
Basic Res Cardiol; 2009 Jan; 104(1):90-9. PubMed ID: 18795223
[TBL] [Abstract][Full Text] [Related]
5. Systematic in vivo candidate evaluation uncovers therapeutic targets for LMNA dilated cardiomyopathy and risk of Lamin A toxicity.
Tan CY; Chan PS; Tan H; Tan SW; Lee CJM; Wang JW; Ye S; Werner H; Loh YJ; Lee YL; Ackers-Johnson M; Foo RSY; Jiang J
J Transl Med; 2023 Oct; 21(1):690. PubMed ID: 37840136
[TBL] [Abstract][Full Text] [Related]
6. Effects of mechanical stress and carvedilol in lamin A/C-deficient dilated cardiomyopathy.
Chandar S; Yeo LS; Leimena C; Tan JC; Xiao XH; Nikolova-Krstevski V; Yasuoka Y; Gardiner-Garden M; Wu J; Kesteven S; Karlsdotter L; Natarajan S; Carlton A; Rainer S; Feneley MP; Fatkin D
Circ Res; 2010 Feb; 106(3):573-82. PubMed ID: 20019332
[TBL] [Abstract][Full Text] [Related]
7. Genotype Complements the Phenotype: Identification of the Pathogenicity of an LMNA Splice Variant by Nanopore Long-Read Sequencing in a Large DCM Family.
Sedaghat-Hamedani F; Rebs S; Kayvanpour E; Zhu C; Amr A; Müller M; Haas J; Wu J; Steinmetz LM; Ehlermann P; Streckfuss-Bömeke K; Frey N; Meder B
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293084
[TBL] [Abstract][Full Text] [Related]
8. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
van Tintelen JP; Hofstra RM; Katerberg H; Rossenbacker T; Wiesfeld AC; du Marchie Sarvaas GJ; Wilde AA; van Langen IM; Nannenberg EA; van der Kooi AJ; Kraak M; van Gelder IC; van Veldhuisen DJ; Vos Y; van den Berg MP;
Am Heart J; 2007 Dec; 154(6):1130-9. PubMed ID: 18035086
[TBL] [Abstract][Full Text] [Related]
9. DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.
Chen SN; Lombardi R; Karmouch J; Tsai JY; Czernuszewicz G; Taylor MRG; Mestroni L; Coarfa C; Gurha P; Marian AJ
Circ Res; 2019 Mar; 124(6):856-873. PubMed ID: 30696354
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cardiac involvement in patients with
Ling X; Hou Y; Jia X; Lan Y; Wu X; Wu J; Jie W; Liu H; Huang S; Wan Z; Li T; Guo J; Liang T
Front Genet; 2023; 14():1291411. PubMed ID: 38259623
[No Abstract] [Full Text] [Related]
11. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.
Wolf CM; Wang L; Alcalai R; Pizard A; Burgon PG; Ahmad F; Sherwood M; Branco DM; Wakimoto H; Fishman GI; See V; Stewart CL; Conner DA; Berul CI; Seidman CE; Seidman JG
J Mol Cell Cardiol; 2008 Feb; 44(2):293-303. PubMed ID: 18182166
[TBL] [Abstract][Full Text] [Related]
12. Lamin A/C Ablation Restricted to Vascular Smooth Muscle Cells, Cardiomyocytes, and Cardiac Fibroblasts Causes Cardiac and Vascular Dysfunction.
Del Monte-Monge A; Ruiz-Polo de Lara Í; Gonzalo P; Espinós-Estévez C; González-Amor M; de la Fuente-Pérez M; Andrés-Manzano MJ; Fanjul V; Gimeno JR; Barriales-Villa R; Dorado B; Andrés V
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446344
[TBL] [Abstract][Full Text] [Related]
13. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations.
Taylor MR; Fain PR; Sinagra G; Robinson ML; Robertson AD; Carniel E; Di Lenarda A; Bohlmeyer TJ; Ferguson DA; Brodsky GL; Boucek MM; Lascor J; Moss AC; Li WL; Stetler GL; Muntoni F; Bristow MR; Mestroni L;
J Am Coll Cardiol; 2003 Mar; 41(5):771-80. PubMed ID: 12628721
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel mutations in LMNA associated with familial forms of dilated cardiomyopathy.
Stallmeyer B; Koopmann M; Schulze-Bahr E
Genet Test Mol Biomarkers; 2012 Jun; 16(6):543-9. PubMed ID: 22224630
[TBL] [Abstract][Full Text] [Related]
15. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease.
Arbustini E; Pilotto A; Repetto A; Grasso M; Negri A; Diegoli M; Campana C; Scelsi L; Baldini E; Gavazzi A; Tavazzi L
J Am Coll Cardiol; 2002 Mar; 39(6):981-90. PubMed ID: 11897440
[TBL] [Abstract][Full Text] [Related]
16. The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy leads to reduced expression and a skewed ratio of lamin A and lamin C proteins.
Al-Saaidi R; Rasmussen TB; Palmfeldt J; Nissen PH; Beqqali A; Hansen J; Pinto YM; Boesen T; Mogensen J; Bross P
Exp Cell Res; 2013 Nov; 319(19):3010-9. PubMed ID: 24001739
[TBL] [Abstract][Full Text] [Related]
17. Lamin A/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation.
Hasselberg NE; Haland TF; Saberniak J; Brekke PH; Berge KE; Leren TP; Edvardsen T; Haugaa KH
Eur Heart J; 2018 Mar; 39(10):853-860. PubMed ID: 29095976
[TBL] [Abstract][Full Text] [Related]
18. Plasma microRNAs as biomarkers for Lamin A/C-related dilated cardiomyopathy.
Toro R; Blasco-Turrión S; Morales-Ponce FJ; Gonzalez P; Martínez-Camblor P; López-Granados A; Brugada R; Campuzano O; Pérez-Serra A; Rosa Longobardo F; Mangas A; Llorente-Cortes V; de Gonzalo-Calvo D
J Mol Med (Berl); 2018 Aug; 96(8):845-856. PubMed ID: 30008018
[TBL] [Abstract][Full Text] [Related]
19. Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity.
Cattin ME; Bertrand AT; Schlossarek S; Le Bihan MC; Skov Jensen S; Neuber C; Crocini C; Maron S; Lainé J; Mougenot N; Varnous S; Fromes Y; Hansen A; Eschenhagen T; Decostre V; Carrier L; Bonne G
Hum Mol Genet; 2013 Aug; 22(15):3152-64. PubMed ID: 23575224
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
